BRAF and liver cancer: In addition, immunotherapeutic drugs combined with other classical drugs have also shown good efficacy in a variety of tumors, such as ICIs combined with angiogenesis inhibitors for liver cancer or combined with BRAF inhibitors for advanced melanoma with BRAF V600 mutation14,15.